Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
150 hedge funds and large institutions have $1.73B invested in Ventyx Biosciences in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 30 reducing their positions, and 25 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 30
16% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 25
4.44% more ownership
Funds ownership: 85.47% → 89.91% (+4.4%)
3% more funds holding
Funds holding: 146 → 150 (+4)
4% more capital invested
Capital invested by funds: $1.67B → $1.73B (+$59.7M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
77% less call options, than puts
Call options by funds: $7.2M | Put options by funds: $31.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$43.6M |
| 2 |
BlackRock
New York
|
+$40.6M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$34.4M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$34.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VP
venBio Partners
San Francisco,
California
|
-$64.6M |
| 2 |
RI
RTW Investments
New York
|
-$46.5M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$42.2M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$14.2M |
VTYX Hedge Fund Activity: Q2 2023 in Review
150 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q2 2023, worth a combined $1.73B — up 3.6% from $1.67B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new VTYX positions and 25 closed out — a net gain of 4 holders — while 70 added to existing stakes and 30 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $43.6M. The largest seller was venBio Partners, cutting an estimated $64.6M.
- 150 institutional investors held Ventyx Biosciences (VTYX) as of Q2 2023, up from 146 in Q1 2023.
- Funds reported $1.73B of Ventyx Biosciences stock for Q2 2023, up 3.6% quarter-over-quarter.
- 29 funds opened new Ventyx Biosciences positions in Q2 2023 and 25 closed out, a net change of +4 holders.
- The largest Ventyx Biosciences buyer in Q2 2023 was T. Rowe Price Associates, an estimated $43.6M added.
- The largest Ventyx Biosciences seller in Q2 2023 was venBio Partners, an estimated $64.6M sold.
Based on aggregated 13F filings for Q2 2023.